Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 11 of 100
Commentary
Aging is the inflation of life. An emerging crop of longevity biotech companies needs investment to beat it
By
Alex Zhavoronkov
September 9, 2024
Leadership
The Coins2Day 500 is built on more than money. It’s built on human, social, and natural capital, too
By
Andre Hoffmann
and
Peter Vanham
September 6, 2024
Tech
Half of Denmark’s GDP growth in 2024 will be thanks to Novo Nordisk, analysts predict
By
Sanne Wass
and
Bloomberg
September 3, 2024
Health
New COVID vaccines are here. What to know about latest shots in wake of nation’s biggest summer surge
By
Lindsey Leake
August 29, 2024
Commentary
Big Tech wants to keep stealing patents—so it’s going to war with Big Pharma
By
Andrei Iancu
and
David J. Kappos
August 28, 2024
Finance
Novo Nordisk’s weight-loss drugs and Bavarian Nordic’s mpox vaccine help fatten up the Danish economy
By
Sanne Wass
and
Bloomberg
August 20, 2024
Tech
This startup believes shopping around for prescription drugs should be as easy as shopping on Amazon. The future of a $700 billion industry is at stake
By
Jason Del Rey
August 15, 2024
Mind
Antidepressant not working? AI may do a better job than your doctor in matching you with the best medicine
By
Lindsey Leake
August 14, 2024
Health
Exclusive: The COO of Hims & Hers was the third person to try their new weight loss drugs—and she’s ready to share her story
By
Alexa Mikhail
August 14, 2024
Commentary
Here’s the real reason Ozempic-like weight-loss drugs are so popular
By
Bill Novelli
August 12, 2024
Health
FDA rejects psychedelic drug MDMA as a treatment for PTSD
By
Matthew Perrone
and
The Associated Press
August 10, 2024
Health
Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits
By
Bloomberg
August 7, 2024
Health
How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices
By
Arthur Allen
and
KFF Health News
August 7, 2024
Commentary
Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
By
Michael Sapienza
August 2, 2024
Magazine
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
By
Erika Fry
August 2, 2024
Most Popular
North America
Gates Foundation plans to give away $9 billion in 2026 to prepare for the 2045 closure while slashing hundreds of jobs
By
Sydney Lake
Europe
Denmark offered to trade Greenland to the U.S. in 1910—and America thought it was crazy
By
Steven Lamy
and
The Conversation
Personal Finance
Sweden abolished its wealth tax 20 years ago. Then it became a 'paradise for the super-rich'
By
Miranda Sheild Johansson
and
The Conversation